Thorax

Papers
(The H4-Index of Thorax is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Vaping and CBD: can new technology overcome old problems?184
Case-based discussion: neonates on extracorporeal membrane oxygenation for undiagnosed recalcitrant pulmonary hypertension—management challenges142
Journal club118
E-cigarette use in young adults and adolescents: not so safe?113
Fibrosing mediastinitis: ‘haemoptysis in the Heartland’111
Strengthening the evidence base to support stronger regulation of social media based advertising of e-cigarette products to youth111
Beware, vaping e-cigarettes around children is adversely impacting their lung health94
Ablation for lung cancer: hot or cold intervention84
Neuropsychiatric diagnoses after montelukast initiation in paediatric patients with asthma72
Emulated trial investigating effects of multiple treatments: estimating combined effects of mucoactive nebulisers in cystic fibrosis using registry data67
Correction:British Thoracic Society Winter Meeting 202364
Rectal organoid morphometric analysis (ROMA)—re: optimising measurements automatically63
Effects of tobacco smoking on recurrent hospitalisation with pneumonia: a population-based cohort study62
Complex coexistence of COPD and cardiovascular disease62
British Thoracic Society Guideline for pleural disease61
Automatic oxygen titration versus constant oxygen flow rates during walking in COPD: a randomised controlled, double-blind, crossover trial61
TB PCR in BAL and EBUS-TBNA samples for the diagnosis of pulmonary and mediastinal lymph node TB: retrospective TRiBE study61
Ambient heat exposure and COPD hospitalisations in England: a nationwide case-crossover study during 2007–201858
Ultra-low-dose CT versus chest X-ray for patients suspected of pulmonary disease at the emergency department: a multicentre randomised clinical trial56
Lung development genes, adult lung function and cardiovascular comorbidities54
Correction:RAGE-induced ILC2 expansion in acute lung injury due to haemorrhagic shock50
Highlights from this issue47
Lower airway microbiota in COPD and healthy controls45
Association between vitamin D status at 3 years and eosinophilic asthma in 6-year-old children with a history of severe bronchiolitis45
Muscle memory: genetic factors underlying functional impairment in COPD44
Prevalence of lung cysts in adolescents and adults with a germlineDICER1pathogenic/likely pathogenic variant: a report from the National Institutes of Health and International Pleuropulmonary B44
Implications of the 2022 lung function update and GLI global reference equations among patients with interstitial lung disease43
Ageing and ivacaftor: unravelling the long-term effects43
BTS Clinical Statement on air travel for passengers with respiratory disease42
Short-term exposure to ultrafine particles and asthma hospital admissions in children in Copenhagen, Denmark41
Airflow obstruction, impaired lung function and risk of sudden cardiac death: a prospective cohort study41
Impact of sex on severe asthma: a cross-sectional retrospective analysis of UK primary and specialist care39
Intensive care unit interventions to promote sleep and circadian biology in reducing incident delirium: a scoping review39
Lung function as independent predictor of cardiovascular disease risk: implications for practice and policy37
Differentiation of malignant from benign pleural effusions based on artificial intelligence37
Toxic metals and lung health: silent poisons?37
Activation of epithelial and inflammatory pathways in adolescent elite athletes exposed to intense exercise and air pollution36
COPD in Africa: risk factors, hospitalisation, readmission and associated outcomes—a systematic review and meta-analysis36
Paediatric asthma hospitalisations continue to decrease in Finland and Sweden between 2015 and 202036
0.25337314605713